Therapeutic effects and mechanisms of isoxanthohumol on DSS-induced colitis: regulating T cell development, restoring gut microbiota, and improving metabolic disorders
Inflammopharmacology · 2024
DOI: 10.1007/s10787-024-01472-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammopharmacology, 2024. Verfasst von Ya-Na Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry (Shaanxi Normal University), The Ministry of Education, College of Life Sc…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Xanthones, Dextran Sulfate, Colitis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a severe hazard to human health. Since pathogenesis of UC is still unclear, current therapy for UC treatment is far from optimal. Isoxanthohumol (IXN), a prenylflavonoid from hops and beer, possesses anti-microbial, anti-oxidant, anti-inflammatory, and anti-angiogenic properties. However, the potential effects of IXN on the alleviation of colitis and the action of the mechanism is rarely studied. Here, we found that administration of IXN (60 mg/kg/day, gavage) significantly attenuated dextran sodium sulfate (DSS)-induced colitis, evidenced by reduced DAI scores and histological improvements, as well as suppressed the pro-inflammatory Th17/Th1 cells but promoted the anti-inflammatory Treg cells. Mechanically, oral IXN regulated T cell development, including inhibiting CD4+ T cell proliferation, promoting apoptosis, and regulating Treg/Th17 balance. Furthermore, IXN relieved colitis by restoring gut microbiota disorder and increasing gut microbiota diversity, which was manifested by maintaining the ratio of Firmicutes/Bacteroidetes balance, promoting abundance of Bacteroidetes and Ruminococcus, and suppressing abundance of proteobacteria. At the same time, the untargeted metabolic analysis of serum samples showed that IXN promoted the upregulation of D-( +)-mannose and L-threonine and regulated pyruvate metabolic pathway. Collectively, our findings revealed that IXN could be applied as a functional food component and served as a therapeutic agent for the treatment of UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry (Shaanxi Normal University), The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, Shaanxi, China.
- Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry (Shaanxi Normal University), The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, Shaanxi, China. yuan…
- Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry (Shaanxi Normal University), The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, Shaanxi, China. xing…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, Y. N., Han, B., Zhang, M. Q., Chai, N. N., Yu, F. L., Qi, W. H., Tian, M. Y., Sun, D. Z., Huang, Y., Song, Q. X., Li, Y., Zhu, M. C., Zhang, Y., & Li, X. (2024). Therapeutic effects and mechanisms of isoxanthohumol on DSS-induced colitis: regulating T cell development, restoring gut microbiota, and improving metabolic disorders. Inflammopharmacology. https://doi.org/10.1007/s10787-024-01472-5
Vancouver
Yang YN, Han B, Zhang MQ, Chai NN, Yu FL, Qi WH, et al. Therapeutic effects and mechanisms of isoxanthohumol on DSS-induced colitis: regulating T cell development, restoring gut microbiota, and improving metabolic disorders. Inflammopharmacology. 2024. doi:10.1007/s10787-024-01472-5
BibTeX
@article{Yang2024,
author = {Yang, Ya-Na and Han, Bing and Zhang, Mao-Qing and Chai, Na-Nan and Yu, Feng-Lin and Qi, Wen-Hui and Tian, Meng-Yuan and Sun, Dong-Zhi and Huang, Ying and Song, Qing-Xin and Li, Yan and Zhu, Mao-Cui and Zhang, Yuan and Li, Xing},
title = {Therapeutic effects and mechanisms of isoxanthohumol on DSS-induced colitis: regulating T cell development, restoring gut microbiota, and improving metabolic disorders},
journal = {Inflammopharmacology},
year = {2024},
doi = {10.1007/s10787-024-01472-5}
}
EUVIMED